2l6s: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 2l6s is ON HOLD Authors: Muench, J., Staendker, L., Adermann, K., Schulz, A., Schindler, M., Chinnadurai, R., Pohlmann, S., Chaipan, C., BieT, T., P... |
No edit summary |
||
| (13 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide== | |||
<StructureSection load='2l6s' size='340' side='right'caption='[[2l6s]]' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[2l6s]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2L6S OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2L6S FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2l6s FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l6s OCA], [https://pdbe.org/2l6s PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2l6s RCSB], [https://www.ebi.ac.uk/pdbsum/2l6s PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2l6s ProSAT]</span></td></tr> | |||
</table> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Adermann K]] | |||
[[Category: Albrecht U]] | |||
[[Category: Barlos K]] | |||
[[Category: Busmann A]] | |||
[[Category: Canales-Mayordomo A]] | |||
[[Category: Forssmann W]] | |||
[[Category: Gimenez-Gallego G]] | |||
[[Category: Hirsch J]] | |||
[[Category: Jimenez-Barbero J]] | |||
[[Category: Kirchhoff F]] | |||
[[Category: Meyer-Olson D]] | |||
[[Category: Muench J]] | |||
[[Category: Perez-Castells J]] | |||
[[Category: Schmidt RE]] | |||
[[Category: Standker L]] | |||
[[Category: Stoll M]] | |||
[[Category: The Y]] | |||
Latest revision as of 06:53, 1 May 2024
Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide
| ||||||||||||
